Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

Hydrochlorothiazide - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrochlorothiazide and what is the scope of freedom to operate?

Hydrochlorothiazide
is the generic ingredient in sixty-three branded drugs marketed by Leading Pharma Llc, Watson Labs, Allergan Sales Llc, Halsey, Roxane, Ivax Sub Teva Pharms, Prinston Inc, Actavis Elizabeth, Impax Labs, Ipca Labs Ltd, Unichem, Jubilant Cadista, Whiteworth Town Plsn, Sun Pharm Inds Inc, Vangard, Mylan, Sandoz, Sciegen Pharms Inc, Aurolife Pharma Llc, Solvay, Teva, Lannett, Superpharm, Usl Pharma, Heather, Mylan Pharms Inc, Merck, Ascot, Alembic Pharms Ltd, Elkins Sinn, Alra, Accord Hlthcare, Dava Pharms Inc, Morton Grove, Lannett Holdings Inc, Aurobindo Pharma, Tg United Labs, Inwood Labs, Barr, Abbvie, Abc Holding, Sun Pharm Inds, Apotex, Hikma Intl Pharms, Heritage Pharms Inc, Warner Chilcott, Mast Mm, Novartis, Pvt Form, West Ward, Dr Reddys Labs Ltd, Apotex Inc, Macleods Pharms Ltd, Lupin Ltd, Aurobindo Pharma Ltd, Atlas Pharms Llc, Watson Labs Inc, West-ward Pharms Int, Sanofi Aventis Us, Hisun Pharm Hangzhou, Schering, Glaxosmithkline, Aurobindo, Sun Pharm Inds Ltd, Lupin, Alvogen Malta, Torrent Pharms, Cadista Pharms, Teva Pharms, Zydus Pharms Usa Inc, Merck Sharp Dohme, Parke Davis, Par Pharm, Purepac Pharm, Concordia Pharms Inc, Us Pharms Holdings I, Glenmark Pharms, Ucb Inc, Chartwell Rx, Daiichi Sankyo, Ani Pharms Inc, Duramed Pharms Barr, Wyeth Pharms Inc, Wyeth Ayerst, Apotex Corp, Pfizer Pharms, Invagen Pharms, Gavis Pharms, Pharmeral, Ivax Pharms, Lederle, Gd Searle Llc, Upsher Smith, Mutual Pharm, Boehringer Ingelheim, Torrent Pharms Ltd, Am Therap, Pliva, Vitarine, Glaxosmithkline Llc, Quantum Pharmics, and Alembic Ltd, and is included in three hundred and eleven NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for hydrochlorothiazide. Seventy-six suppliers are listed for this compound. There are three tentative approvals for this compound.

Summary for Generic Name: hydrochlorothiazide

Tradenames:63
Patents:5
Applicants:102
NDAs:311
Drug Master File Entries: see list31
Suppliers / Packagers: see list76
Bulk Api Vendors: see list77
Clinical Trials: see list82
Patent Applications: see list7,229
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydrochlorothiazide at DailyMed

Pharmacology for Ingredient: hydrochlorothiazide

Ingredient-typeThiazides
Drug ClassThiazide Diuretic
Physiological EffectIncreased Diuresis

Tentative approvals for HYDROCHLOROTHIAZIDE

Applicant Application No. Form Dosage
► Subscribe► SubscribeTABLET; ORAL25MG;300MG
► Subscribe► SubscribeTABLET; ORAL12.5MG; 150MG
► Subscribe► SubscribeTABLET; ORAL12.5MG; 300MG
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; triamterene
TABLET;ORAL071969-001Apr 17, 1988DISCNNoNo► Subscribe► Subscribe
Macleods Pharms Ltd
IRBESARTAN AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; irbesartan
TABLET;ORAL202414-002Sep 27, 2012ABRXNoNo► Subscribe► Subscribe
Aurobindo
LISINOPRIL AND HYDROCHLOROTHIAZIDE
hydrochlorothiazide; lisinopril
TABLET;ORAL077606-001Mar 14, 2006ABRXNoNo► Subscribe► Subscribe
Daiichi Sankyo
BENICAR HCT
hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL021532-005Jun 5, 2003ABRXYesYes5,616,599*PED► Subscribe ► Subscribe
Daiichi Sankyo
BENICAR HCT
hydrochlorothiazide; olmesartan medoxomil
TABLET;ORAL021532-002Jun 5, 2003ABRXYesNo5,616,599*PED► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot